0001209191-20-010481.txt : 20200219 0001209191-20-010481.hdr.sgml : 20200219 20200219160431 ACCESSION NUMBER: 0001209191-20-010481 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200214 FILED AS OF DATE: 20200219 DATE AS OF CHANGE: 20200219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cassella James V CENTRAL INDEX KEY: 0001353528 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36310 FILM NUMBER: 20629636 MAIL ADDRESS: STREET 1: 2091 STIERLIN COURT CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001367920 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVENUE STREET 2: SUITE 3000N CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-860-0045 MAIL ADDRESS: STREET 1: 65 HAYDEN AVENUE STREET 2: SUITE 3000N CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060628 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-14 0 0001367920 CONCERT PHARMACEUTICALS, INC. CNCE 0001353528 Cassella James V C/O CONCERT PHARMACEUTICALS, INC. 65 HAYDEN AVENUE, SUITE 3000N LEXINGTON MA 02421 0 1 0 0 Chief Development Officer Common Stock 2020-02-14 4 A 0 28216 A 80481 D Stock Option (Right to Buy) 10.87 2020-02-14 4 A 0 42430 0.00 A 2030-02-13 Common Stock 42430 42430 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs granted to Mr. Cassella will vest in three equal annual installments measured from the date of grant. The number above represents the maximum number of shares that may be delivered pursuant to the award. Not applicable. The shares underlying this option vest in equal quarterly installments over a four-year period measured from the date of grant. /s/ Nancy Stuart as Attorney-in-Fact for James V. Cassella 2020-02-19